Purpose: To develop a quality assurance (QA) procedure to assess the intens
ity profile and dosimetry for intensity-modulated (IM) treatment fields usi
ng electronic portal imaging devices (EPIDs),
Methods and Materials: A series of rapidly acquired (similar to 1/sec) port
al images are summed and converted to dose, For relative intensity QA, the
intended profile is subtracted point-by-point from the measured profile for
ming a series of error values. The standard deviation, a, of the errors, a
measure of the goodness of the match, is minimized by applying a normalizat
ion and uniform scatter subtraction from the measured profile. For dose ver
ification (dose to isocenter), an empirically determined phantom-correction
factor is added to incorporate the effect of patient presence on EPID read
ings. Seventy prostate treatment fields were used in a phantom study to ver
ify these approaches, Sensitivity was studied by creating artificial mismat
ches.
Results: The average a for relative profile verification is 3.3% (percentag
e of average intended intensity) whereas artificial mismatches resulted in
a values from 5% to 27%, The average isocentric dose calculated from EPID r
eadings is 1.001 relative to the planned dose with a standard deviation of
0.018.
Conclusions: An EPID can be used for profile verification and absolute isoc
entric dose measurement for IM fields. (C) 2000 Elsevier Science Inc.